SEC Form 4 · accession 0001179110-18-002037
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Feb 13, 2018
Accepted (ET)
Feb 14, 2018 · 10:39 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 13, 2018 | M | 46,667 | $3.30 | A | 243,367 | D | |
| Common StockF2 | Feb 13, 2018 | S | 46,667 | $10.0125 | D | 196,700 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.30 | Feb 13, 2018 | M | 46,667 | D | Jun 11, 2009 | Jun 11, 2018 | Common Stock | 46,667 | 0 | D |
Explanation of responses
- F1Exercisable as to 23,334 shares commencing on June 11, 2009 and 23,333 shares commencing on June 11, 2010.
- F2Weighted average price of shares sold.